e-learning
resources
ERJ
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nontraumatic chylothorax and previous cancer: a role for positron emission tomography?
Garcia-Zamalloa A.
Source:
Eur Respir J 2005; 26: 749-750
Journal Issue:
October
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Garcia-Zamalloa A.. Nontraumatic chylothorax and previous cancer: a role for positron emission tomography?. Eur Respir J 2005; 26: 749-750
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 227s
Year: 2001
The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245
Year: 2004
Does positron emission tomography (PET/CT) have a role to play in the management of patients presenting with pleural changes suggestive of malignancy
Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools
Year: 2009
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
Source: Eur Respir J 2009; 33: 201-212
Year: 2009
Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for patients with presumed or established lung cancer
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008
Imaging the inflammatory activity of sarcoidosis
Source: Eur Respir J 2013; 41: 743-751
Year: 2013
Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET)
Source: Eur Respir J 2001; 18: Suppl. 33, 396s
Year: 2001
Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer
Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer
Year: 2008
Rebuttal
Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems?
Year: 2005
Advances in chest imagery
Source: Annual Congress 2006 - Clinical year in review
Year: 2006
Positron emission tomography findings in round atelectasis
Source: Annual Congress 2009 - Old and new: technique and pathology
Year: 2009
Clinicopathologic comparison of computed tomography and positron emission tomography scanning for mediastinal staging in NSCLC
Source: Annual Congress 2010 - Actual challenges in thoracic surgery
Year: 2010
Imaging in lung cancer: positron emission tomography scan
Source: Eur Respir J 2002; 19: 49S-60S
Year: 2002
(18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Assessing nodules detected in lung cancer screening: the value of positron emission tomography
Source: Eur Respir J 2015; 45: 314-316
Year: 2015
Primary pulmonary artery sarcomas: improvement of preoperative diagnostic by positron emission tomography
Source: Eur Respir J 2005; 26: Suppl. 49, 312s
Year: 2005
New imaging techniques in the treatment guidelines for lung cancer
Source: Eur Respir J 2002; 19: 71S-83S
Year: 2002
Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002
Positron emission tomography in sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 212s
Year: 2005
Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection and staging of bronchioloalveolar carcinoma
Source: Eur Respir J 2001; 18: Suppl. 33, 18s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept